This website uses cookies
Read our Privacy policy and Terms of use for more information.
Jul 22, 2026
•
3 min read
And the patients on it are your next churn risk.
Jul 15, 2026
Your contact list may have crossed the line.
Jul 8, 2026
4 min read
They return to whoever’s in front of them.
Jul 1, 2026
Cheaper access means lower-commitment patients
Jun 24, 2026
The cheaper growth play is already on your list.
Jun 17, 2026
The price-jump play if/when patients switch to branded.
Jun 10, 2026
The $1.15B reason Hims' CAC math beats yours.
Jun 3, 2026
What it means when meds become the cheap part...
May 27, 2026
Most telehealth lifecycles end at goal weight, and that’s the retention cliff.
May 20, 2026
The Hims and Ro duopoly is now competing on price. For private telehealth brands, plan length is the retention lever most aren't using.
May 13, 2026
5 min read
Novo’s Q1 print confirms the oral GLP-1 cohort is real and growing fast
May 6, 2026
The cash-pay GLP-1 cohort to identify now and the patient experience that protects them.
Apr 29, 2026
What changes when the biggest retailer in America enters your category at the lowest price.
Apr 22, 2026
Who still has a moat when GLP-1 turns into a commodity.
Apr 15, 2026
6 min read
Your GLP-1 retention playbook just broke. Here's what changed
